tradingkey.logo

Thermo Fisher Scientific Inc

TMO
查看詳細走勢圖
542.830USD
+0.360+0.07%
收盤 02/06, 16:00美東報價延遲15分鐘
203.95B總市值
30.53本益比TTM

Thermo Fisher Scientific Inc

542.830
+0.360+0.07%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.07%

5天

-6.18%

1月

-12.04%

6月

+19.37%

今年開始到現在

-6.32%

1年

-5.01%

查看詳細走勢圖

TradingKey Thermo Fisher Scientific Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Thermo Fisher Scientific Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名16/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為664.87。中期看,股價處於平穩狀態。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Thermo Fisher Scientific Inc評分

相關信息

行業排名
16 / 205
全市場排名
89 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看跌

Thermo Fisher Scientific Inc亮點

亮點風險
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
行業龍頭
公司營業收入處於行業前列,最新年度總收入44.56B美元
高分紅
公司屬於高分紅公司,最新股息支付率9.41%
穩定分紅
公司5年內持續分紅,最新股息支付率9.41%
估值低估
公司最新PE估值30.53,處於3年歷史低位
機構減倉
最新機構持股348.27M股,環比減少1.83%
布蘭德斯投資公司持倉
明星投資者布蘭德斯投資公司持倉,最新持倉185.00股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.04

分析師目標

基於 29 分析師
買入
評級
664.867
目標均價
+17.63%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Thermo Fisher Scientific Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Thermo Fisher Scientific Inc簡介

Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
公司代碼TMO
公司Thermo Fisher Scientific Inc
CEOCasper (Marc N)
網址https://corporate.thermofisher.com/us/en/index.html
KeyAI